These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9122262)

  • 41. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Saller CF; Kreamer LD; Adamovage LA; Salama AI
    Life Sci; 1989; 45(10):917-29. PubMed ID: 2529407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
    Norman AB; Wachendorf TJ; Sanberg PR
    Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
    J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial nicotinamide nucleotide transhydrogenase: nonidentical modification by N,N'-dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline at the NAD(H) binding site.
    Phelps DC; Hatefi Y
    Arch Biochem Biophys; 1985 Nov; 243(1):298-304. PubMed ID: 4062305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
    Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reactivity of gastric (H+ + K+)-ATPase to N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Saccomani G; Barcellona ML; Sachs G
    J Biol Chem; 1981 Dec; 256(23):12405-10. PubMed ID: 6117558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
    Lévesque D; Di Paolo T
    Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of halobacterial Na+/H(+)-antiporter by carboxyl modifying reagent, EEDQ.
    Niwano K; Murakami N; Okazawa K; Konishi T
    Biochem Int; 1991 Sep; 25(1):173-9. PubMed ID: 1663350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An in vivo procedure for the selective inactivation of rat brain cerebral cortical alpha-adrenoceptors using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Pilc A; Vetulani J; Nomura S; Enna SJ
    Brain Res; 1989 Jul; 493(1):8-13. PubMed ID: 2570619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, amiloride analogues, and renal Na+/H+ antiporter.
    Rocco VK; Cragoe EJ; Warnock DG
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F517-24. PubMed ID: 3030138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex.
    Adler CH; Meller E; Goldstein M
    J Pharmacol Exp Ther; 1987 Feb; 240(2):508-15. PubMed ID: 3027315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets.
    Biessen EA; Norder JA; Horn AS; Robillard GT
    Biochem Pharmacol; 1988 Oct; 37(20):3959-66. PubMed ID: 2847749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
    Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
    Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.